BONE-MARROW TRANSPLANTATION FOR LEUKEMIA AFTER CONDITIONING WITH BUSULFAN AND CYCLOPHOSPHAMIDE - BONE-MARROW MORPHOLOGY IN THE EARLY RECOVERY PHASE

被引:0
|
作者
CAO, DC
TUTSCHKA, PJ
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The bone marrow morphology of fifty patients with leukemia was analyzed before and two weeks after allogeneic bone marrow transplantation and compared to that of ten normal, healthy control subjects. Conditioning of the marrow graft recipients had been carried out with a combination of 16 mg / kg of Busulfan and 120 mg / kg of cyclophosphamide. The bone marrow at two weeks after transplant showed characteristic features that were unique for this clinical setting. Regenerative precursor cells with a distinct morphology commonly formed clusters or islands. Although mixed, multilinear islands were seen; the majority of islands were unilinear with a homogeneous cell content. These hematopoietic colonies were in direct proximity to degenerated cells of presumed host origin. No damage to the microenvironment was seen, the most characteristic finding being large, uniform, unilocular fat cells in close proximity to regenerative precursor cells. These morphologic changes are indicative of a complete and persistent marrow engraftment.
引用
收藏
页码:267 / 276
页数:10
相关论文
共 50 条
  • [1] BONE-MARROW TRANSPLANTATION FOR LEUKEMIA FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE
    POLCHI, P
    GALIMBERTI, M
    LUCARELLI, G
    GIARDINI, C
    MANENTI, F
    DURAZZI, SMT
    BOCCONCELLI, A
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 547 - 547
  • [2] HEMATOPOIETIC RECONSTITUTION AFTER BUSULFAN CYCLOPHOSPHAMIDE CONDITIONING AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SZCZYLIK, C
    RATAJCZAK, MZ
    URBANOWSKA, E
    WIKTORJEDRZEJCZAK, W
    BLUT, 1988, 57 (04): : 235 - 235
  • [3] BUSULFAN/CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA
    ODONNELL, MR
    LONG, GD
    PARKER, PM
    NILAND, J
    NADEMANEE, A
    AMYLON, M
    CHAO, N
    NEGRIN, RS
    SCHMIDT, GM
    SLOVAK, ML
    SMITH, EP
    SNYDER, DS
    STEIN, AS
    TRAWEEK, T
    BLUME, KG
    FORMAN, SJ
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) : 2973 - 2979
  • [4] TREATMENT OF INFANT LEUKEMIA WITH BUSULFAN, CYCLOPHOSPHAMIDE +/- ETOPOSIDE AND BONE-MARROW TRANSPLANTATION
    EMMINGER, W
    EMMINGERSCHMIDMEIER, W
    HAAS, OA
    URBAN, C
    AMBROS, P
    PETERS, C
    MANN, G
    FINK, FM
    FERSTL, G
    HOCKER, P
    KOLLER, U
    GADNER, H
    BONE MARROW TRANSPLANTATION, 1992, 9 (05) : 313 - 318
  • [5] BONE-MARROW TRANSPLANTATION FOR LEUKEMIA FOLLOWING A NEW BUSULFAN AND CYCLOPHOSPHAMIDE REGIMEN
    TUTSCHKA, PJ
    COPELAN, EA
    KLEIN, JP
    BLOOD, 1987, 70 (05) : 1382 - 1388
  • [6] BONE-MARROW TRANSPLANTATION FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE FOR ACUTE MYELOGENOUS LEUKEMIA
    CRILLEY, P
    TOPOLSKY, D
    BULOVA, S
    BIGLER, R
    BRODSKY, I
    BONE MARROW TRANSPLANTATION, 1990, 5 (03) : 187 - 191
  • [8] BUSULFAN, CYCLOPHOSPHAMIDE, AND MELPHALAN CONDITIONING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HEMATOLOGIC MALIGNANCY
    PHILLIPS, GL
    SHEPHERD, JD
    BARNETT, MJ
    LANSDORP, PM
    KLINGEMANN, HG
    SPINELLI, JJ
    NEVILL, TJ
    CHAN, KW
    REECE, DE
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (10) : 1880 - 1888
  • [9] EOSINOPHILIA AFTER BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KALAYCIOGLU, M
    BOLWELL, B
    BLOOD, 1993, 82 (10) : A632 - A632
  • [10] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RECURRENCE OF LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SCHWELLA, N
    SCHWERDTFEGER, R
    KONIG, V
    BLASCZYK, R
    SCHMID, H
    SCHMIDTWOLF, I
    HENZE, G
    SIEGERT, W
    TRANSPLANTATION, 1994, 57 (08) : 1263 - 1265